Patient demographics divided by SACQ outcome. Values are mean ± SD or n (%) unless otherwise specified.
| Characteristics | Non-SACQ Patients with SLE, n = 21 | SACQ Patients | ||
|---|---|---|---|---|
| Flare, n = 9 | Quiescent, n = 14 | p Between SACQ Subsets | ||
| Female | 20 (95) | 9 (100) | 11 (78.6) | 0.25 |
| Age at sample date, yrs | 48.5 ± 13.0 | 43.7 ± 15.3 | 47.7 ± 20.5 | 0.73 |
| Disease duration at sample date, yrs | 20.5 ± 9.9 | 20.1 ± 14.4 | 13.7 ± 9.3 | 0.37 |
| Steroids ever | 15 (71.4) | 5 (55.6) | 9 (64.3) | 1.00 |
| Antimalarials ever | 13 (61.9) | 8 (88.9) | 11 (78.6) | 1.00 |
| Immunosuppressives ever | 14 (66.7) | 1 (11.1) | 2 (14.3) | 1.00 |
| Steroids current | 15 (71.4) | N/A | N/A | N/A |
| Steroids dose, mg | 16.8 ± 14.5 | N/A | N/A | N/A |
| Antimalarials current | 13 (61.9) | 6 (66.7) | 7 (50.0) | 0.67 |
| Immunosuppressives current | 14 (66.7) | N/A | N/A | N/A |
SACQ: serologically active clinically quiescent; SLE: systemic lupus erythematosus; N/A: not applicable.